The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts.

Chun-Wei ChenJur-Shan ChengTai-Di ChenPuo-Hsien LeHsin-Ping KuMing-Ling Chang

Published in: Therapeutic advances in gastroenterology (2019)

HCV infection, male sex and old age were risk factors for gastric cancer development. HCV-associated gastric cancer risk might be neither reversed by interferon-based therapy, nor associated with in situ HCV-core-related carcinogenesis.

Keyphrases

hepatitis c virus
human immunodeficiency virus
dendritic cells
stem cells
cross sectional
hiv infected
breast cancer risk